In theory, the application of stem cell technology can treat various diseases, and it has unparalleled advantages over many traditional treatment methods.

However, there are many types of stem cells, and there are also two derivatives of "exosomes" and "supernatant". There are considerable differences between different types.

Human genetic resource information includes data information such as genes, genomes, transcriptome, epigenome, and nucleic acid biomarkers such as ctDNA, as well as related information related to this data, such as diseases and races.

In recent years, neural stem cell (NSC) therapy has brought hope to many patients with nerve damage.

The research and development of new stem cell drugs in China is advancing at a new speed. Nearly 103 clinical trial applications for stem cell drugs have been accepted, and many of these new stem cell drugs have entered the clinical research stage.‌

Kyoto University Hospital is studying a treatment for severe type 1 diabetes that uses induced pluripotent stem cells (iPS) to reprogram into islet cells to produce hormones that regulate blood sugar levels.

Mesenchymal stem cells (MSC) have high plasticity, self-renewal capabilities, immunosuppressive and anti-inflammatory properties, and have become a promising technology for the treatment of knee osteoarthritis (OA).

Many clinical studies have reported the safety and effectiveness of MSC therapy in promoting sports injuries.